Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00074789 · ClinicalTrials.gov registry record · Phase 2
Reducing Symptoms of Depression in Low-Income Mothers
A Phase 2 study of Depression, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 2
- Development phase
- 226
- Enrollment target
- 6
- Study locations
NCT00074789: Completed Phase 2 study of Depression, sponsored by University of North Carolina, Chapel Hill.
NCT00074789 is a Phase 2 study of Depression that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 226 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower). The trial reports 6 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00074789, a Phase 2 study of Depression, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 226 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study will test the effectiveness of a short-term intervention in treating depressed young mothers with young children enrolled in Early Head Start Programs.
Conditions Studied
Interventions
- BEHAVIORAL Modified Interpersonal Therapy
- BEHAVIORAL Attention control/usual care
Study Locations (6)
North Carolina
- Asheville City Schools Preschool-Early Head Start Program - Asheville
- Chapel Hill Training Outreach Project, Inc. Early Head Start - Chapel Hill
- University of North Carolina, Chapel Hill - Chapel Hill
- W.A.G.E.S., Inc. Early Head Start Program - Goldsboro
- United Child Development Services, Inc. Early Head Start - Greensboro
New York
- P.E.A.C.E, Inc. Early Head Start - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2003-06 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
What the finished NCT00074789 record still lists
NCT00074789 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Modified Interpersonal Therapy is the first listed.
NCT00074789 lists 6 locations in 2 states (North Carolina, New York).
Frequently Asked Questions
What is clinical trial NCT00074789 about?
NCT00074789 is a clinical study titled "Reducing Symptoms of Depression in Low-Income Mothers". This study will test the effectiveness of a short-term intervention in treating depressed young mothers with young children enrolled in Early Head Start Programs.
What is the current status of trial NCT00074789?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 226 participants. The study started on 2003-06. Estimated completion is 2009-01.
What conditions does trial NCT00074789 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00074789?
The interventions under investigation include: Modified Interpersonal Therapy (BEHAVIORAL), Attention control/usual care (BEHAVIORAL).
Who is sponsoring clinical trial NCT00074789?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00074789 being conducted?
This trial has 6 study locations across New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00074789's enrollment target sits among peer trials
226 192nd of 679 higher than 486 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
RECRUITING · Phase 2
-
Neurobiology of Suicide
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04419272 · 226 participants · Phase 4
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- NCT05488054 · 226 participants · NA
Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery
- NCT05924477 · 226 participants · NA
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
- NCT06106945 · 226 participants · Phase 1
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia